Hexagon Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22
| Closed | -$14K | – | 1342 |
|
|
2025
Q1 | $14K | Sell |
22
-7
| -24% | -$4.44K | ﹤0.01% | 869 |
|
|
2024
Q4 | $20.7K | Buy |
29
+8
| +38% | +$5.7K | ﹤0.01% | 774 |
|
|
2024
Q3 | $22.1K | Buy |
21
+8
| +62% | +$8.41K | ﹤0.01% | 683 |
|
|
2024
Q2 | $13.7K | Sell |
13
-8
| -38% | -$8.41K | ﹤0.01% | 792 |
|
|
2024
Q1 | $20.2K | Buy |
21
+11
| +110% | +$10.6K | ﹤0.01% | 673 |
|
|
2023
Q4 | $8.78K | Hold |
10
| – | – | ﹤0.01% | 854 |
|
|
2023
Q3 | $8.23K | Sell |
10
-3
| -23% | -$2.47K | ﹤0.01% | 794 |
|
|
2023
Q2 | $9.34K | Hold |
13
| – | – | ﹤0.01% | 763 |
|
|
2023
Q1 | $10.7K | Sell |
13
-2
| -13% | -$1.64K | ﹤0.01% | 716 |
|
|
2022
Q4 | $10.8K | Sell |
15
-12
| -44% | -$8.66K | ﹤0.01% | 710 |
|
|
2022
Q3 | $19K | Buy |
27
+24
| +800% | +$16.9K | 0.01% | 605 |
|
|
2022
Q2 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 995 |
|
|
2020
Q4 | – | Sell |
-50
| Closed | -$27K | – | 744 |
|
|
2020
Q3 | $27K | Buy |
+50
| New | +$27K | 0.01% | 319 |
|